LP
Leerink Partners Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
|
TECX
76
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
|
DR
David Risinger
| $16.80 | $69 |
311%
upside
| Outperform | 9 months ago |
|
77
Zymeworks
ZYME
$1.14B
|
AB
Andrew Berens
| $15.05 | $25 |
66%
upside
| Outperform | 10 months ago |
|
78
Beam Therapeutics
BEAM
$2.11B
|
RB
Rick Bienkowski
| $20.88 | $39 |
87%
upside
| Outperform | 10 months ago |
|
79
IDEAYA Biosciences
IDYA
$2.38B
|
CL
Christopher Liu
| $27.16 | $27 |
1%
downside
| Market Perform | 10 months ago |
|
80
Envista
NVST
$3.54B
|
MC
Michael Cherny
| $21.31 | $23 |
8%
upside
| Market Perform | 10 months ago |
|
81
DexCom
DXCM
$31.6B
|
MK
Mike Kratky
| $80.51 | $87 |
8%
upside
| Outperform | 10 months ago |
|
82
Aquestive Therapeutics
AQST
$656M
|
RR
Roanna Ruiz
| $5.42 | $13 |
140%
upside
| Outperform | 10 months ago |
|
83
Gilead Sciences
GILD
$143B
|
AB
Andrew Berens
| $115.05 | $96 |
17%
downside
| Outperform | 10 months ago |
|
84
Veracyte
VCYT
$2.55B
|
PS
Puneet Souda
| $32.43 | $40 |
23%
upside
| Outperform | 10 months ago |
|
85
Twist Bioscience
TWST
$1.55B
| $25.76 | $48 |
86%
upside
| Market Perform | 10 months ago |
|
|
86
Revvity
RVTY
$10.1B
| $86.64 | $135 |
56%
upside
| Outperform | 10 months ago |
|
|
87
Natera
NTRA
$23.1B
|
PS
Puneet Souda
| $168.02 | $150 |
11%
downside
| Outperform | 10 months ago |
|
88
Illumina
ILMN
$15.7B
| $98.93 | $200 |
102%
upside
| Outperform | 10 months ago |
|
|
89
Mirum Pharmaceuticals
MIRM
$3.82B
|
MF
Mani Foroohar
| $76.06 | $49 |
36%
downside
| Outperform | 10 months ago |
|
90
BridgeBio Pharma
BBIO
$10.2B
|
MF
Mani Foroohar
| $53.38 | $46 |
14%
downside
| Outperform | 10 months ago |
|
91
Guardant Health
GH
$7.5B
| $60.13 | $50 |
17%
downside
| Outperform | 10 months ago |
|
|
92
Wave Life Sciences
WVE
$1.32B
|
MF
Mani Foroohar
| $8.29 | $22 |
165%
upside
| Outperform | 10 months ago |
|
93
Travere Therapeutics
TVTX
$1.93B
|
JS
Joseph Schwartz
| $21.64 | $40 |
85%
upside
| Outperform | 11 months ago |
|
94
McKesson
MCK
$85.5B
|
MC
Michael Cherny
| $687.40 | $630 |
8%
downside
| Outperform | 11 months ago |
|
95
Cencora
COR
$56.7B
|
MC
Michael Cherny
| $292.50 | $275 |
6%
downside
| Outperform | 11 months ago |
|
96
Humana
HUM
$37B
|
WM
Whit Mayo
| $307.92 | $250 |
19%
downside
| Market Perform | 11 months ago |
|
97
Agios Pharmaceuticals
AGIO
$2.09B
|
AB
Andrew Berens
| $36.01 | $56 |
56%
upside
| Market Perform | 11 months ago |
|
|
ORKA
98
Oruka Therapeutics, Inc. Common Stock
ORKA
$612M
|
DR
David Risinger
| $16.35 | $44 |
169%
upside
| Outperform | 11 months ago |
|
99
Trevi Therapeutics
TRVI
$854M
|
FK
Faisal Khurshid
| $7.01 | $7 |
0%
downside
| Outperform | 1 year ago |
|
|
PRTC
100
PureTech Health
PRTC
$392M
|
FK
Faisal Khurshid
| $16.23 | $45 |
177%
upside
| Outperform | 1 year ago |
|